1. MARKETS
  2. SECTOR : HEALTHCARE
  3. INDUSTRY : HEALTHCARE FACILITIES
  4. SAHAJANAND MEDICAL TECHNOLOGIES LTD.
Sahajanand Medical Technologies Ltd.
NSE: SMT | BSE: 545001|ASM

Sahajanand Medical Live Share Price Today, Share Analysis and Chart

aboutSahajanand Medical Technologies was incorporated on September 30, 2001. The company is an R&D-driven; developer of Class III and Class C/D medical devices, focused on Vascular Intervention and Structural Heart solutions. Its portfolio includes corona... Read More
Ask AI about Sahajanand Medical
527.60-11.45(-2.12%)
488.7K
NSE+BSE Volume

NSE 20 Nov, 2026 3:31 PM

Portfolio

Alert

My Notes

Sahajanand Medical Stock Price Ranges

Day Price Range

-2.1% 1 Day return
527.6 (LTP)
519537
LowHigh

Week Price Range

4.6% 1 Week return
527.6 (LTP)
492578.7
LowHigh

Month Price Range

53.4% 1 Month return
527.6 (LTP)
346.6578.7
LowHigh

52 Week Price Range

53.4% 1 Year return
527.6 (LTP)
346.6578.7
LowHigh

Sahajanand Medical Technical Analysis

Sahajanand Medical EMA & SMA

Bullish+2
Bullish3
Bearish1
5 Day534.1
10 Day524.2
12 Day518
20 Day495.9

Sahajanand Medical Delivery And Volume

Daily Avg. Delivery Volume %
20 Nov, 202644.3%
Week33.7%
Month25.4%

Sahajanand Medical Active Candlesticks

Hikkake Uptrend
PositiveNeutralNegative

Sahajanand Medical Resistance and Support

527.87
Pivot
First Resistance536.7
Second Resistance545.9
Third Resistance554.7
First Support518.7
Second Support509.9
Third Support500.7
Day RSI69.5
Day MACD-
Day MFI75.5
Day MACD Signal Line-

Sahajanand Medical Beta

1 Month-
1 Year-
3 Month-
3 Year-

Sahajanand Medical Price Change Analysis

↑53.4%
Over 1 Month
LowHigh
346.7578.7
↑53.4%
Over 3 Months
LowHigh
346.7578.7
↑53.4%
Over 6 Months
LowHigh
346.7578.7
↑53.4%
Over 1 Year
LowHigh
346.7578.7

Sahajanand Medical Shareholding Pattern/ Ownership

Shareholding Summary

 
NameCategorySharesShares %

HISTORICAL PROMOTER HOLDING

HISTORICAL FII HOLDING

HISTORICAL MF HOLDING

Sahajanand Medical Deals - Insider, Bulk, Block and SAST

Client NameDeal TypeActionDateAvg. PriceQuantityExchange
JUMP TRADING FINANCIAL INDIA PRIVATE LIMITEDBulkSell28 Oct 2026508.54555,833NSE
MICROCURVES TRADING PRIVATE LIMITEDBulkSell28 Oct 2026502.01575,186NSE
ALPHAGREP SECURITIES PRIVATE LIMITEDBulkSell28 Oct 2026508.15719,743NSE
JUMP TRADING FINANCIAL INDIA PRIVATE LIMITEDBulkPurchase28 Oct 2026515.65569,867NSE
MICROCURVES TRADING PRIVATE LIMITEDBulkPurchase28 Oct 2026501.64575,186NSE
ALPHAGREP SECURITIES PRIVATE LIMITEDBulkPurchase28 Oct 2026509.43719,743NSE
GRT STRATEGIC VENTURES LLPBulkSell23 Oct 2026382.54538,038NSE
GRT STRATEGIC VENTURES LLPBulkPurchase23 Oct 2026382.37538,038NSE
INVESCO MUTUAL FUNDBulkPurchase23 Oct 2026371.442,807,366NSE
INVESCO MUTUAL FUNDBulkPurchase23 Oct 2026374.91800,000NSE

Sahajanand Medical Corporate Actions

Sahajanand Medical Board Meetings

Sahajanand Medical past and upcoming board meetings.

#Ex-Date
PurposeNotes
105 Nov 2026
Quarterly Results-

Sahajanand Medical Research Reports

Sahajanand Medical research reports with share price targets, and buy/hold/sell recommendations from top brokers.

#
Date
Broker NameTargetPrice When RecommendedTypeUpsideChange Since RecommendationLinks
113 Oct 2026Ventura--IPO Subscribe--%pdf

Sahajanand Medical Corporate Filings

Sahajanand Medical BSE corporate filings and AGM, press releases, insider trading & SAST, results and corporate actions.

DateAnnouncement TitleDetailsLinks
20 Nov 2026
Sahajanand Medical Technologies Ltd - 545001 - Intimation Under Regulation 7(1) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015
Appointment of MUFG Intime India Private Limited as the Registrar & Share Transfer Agent of the Company w.e.f. October 23, 2026 (Date of Listing)
PDF
10 Nov 2026
Sahajanand Medical Technologies Ltd - 545001 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of Analyst/Investor Meet
PDF
08 Nov 2026
Sahajanand Medical Technologies Ltd - 545001 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript of Earnings Call for Q2 & H1 FY27 Financial Results held on Thursday, November 05, 2026.
PDF
06 Nov 2026
Q2FY27 Quarterly Result Announced for Sahajanand Medical Technologies Ltd.
Healthcare Facilities company Sahajanand Medical Technologies announced Q2FY27 results Consolidated Financial Highlights: Revenue from Operations: Stood at Rs 37,341.01 lakh in Q2FY27, growing 6.18% QoQ from Rs 35,166.85 lakh in Q1FY27 and increasing 24.69% YoY compared to Rs 29,947.09 lakh in Q2FY26. Other Income: Reported at Rs 223.58 lakh in Q2FY27, declining 16.04% QoQ from Rs 266.30 lakh in Q1FY27 and down 4.59% YoY compared to Rs 234.33 lakh in Q2FY26. Total Income: Stood at Rs 37,564.59 lakh in Q2FY27, reflecting an increase of 6.02% QoQ compared to Rs 35,433.15 lakh in Q1FY27 and a growth of 24.46% YoY from Rs 30,181.42 lakh in Q2FY26. Profit Before Tax (PBT): Rose to Rs 4,006.87 lakh in Q2FY27, up 64.99% QoQ from Rs 2,428.52 lakh in Q1FY27 and higher by 47.92% YoY compared to Rs 2,708.77 lakh in Q2FY26. Profit After Tax (PAT): Reached Rs 2,646.92 lakh in Q2FY27, registering a sharp growth of 75.38% QoQ compared to Rs 1,509.23 lakh in Q1FY27 and an increase of 26.60% YoY from Rs 2,090.77 lakh in Q2FY26. Net Profit Attributable to Owners of the Company: Stood at Rs 2,579.06 lakh in Q2FY27, up 77.00% QoQ from Rs 1,457.19 lakh in Q1FY27 and up 32.14% YoY from Rs 1,951.69 lakh in Q2FY26. Total Comprehensive Income: Reported at Rs 2,818.00 lakh in Q2FY27, surging 142.47% QoQ from Rs 1,162.22 lakh in Q1FY27, while decreasing 32.52% YoY compared to Rs 4,176.12 lakh in Q2FY26. Earnings Per Share (EPS): Basic EPS stood at Rs 2.63 per share in Q2FY27, up 77.70% QoQ compared to Rs 1.48 per share in Q1FY27 and up 31.50% YoY from Rs 2.00 per share in Q2FY26. Diluted EPS stood at Rs 2.56 per share in Q2FY27, up 76.55% QoQ from Rs 1.45 per share in Q1FY27 and up 31.96% YoY compared to Rs 1.94 per share in Q2FY26. Standalone Financial Highlights: Revenue from Operations: Stood at Rs 15,858.23 lakh in Q2FY27, an increase of 3.38% QoQ compared to Rs 15,339.14 lakh in Q1FY27 and a growth of 17.50% YoY from Rs 13,496.20 lakh in Q2FY26. Other Income: Reported at Rs 194.71 lakh in Q2FY27, up 38.84% QoQ from Rs 140.24 lakh in Q1FY27 and up 12.73% YoY from Rs 172.72 lakh in Q2FY26. Total Income: Stood at Rs 16,052.94 lakh in Q2FY27, rising 3.71% QoQ compared to Rs 15,479.38 lakh in Q1FY27 and increasing 17.44% YoY compared to Rs 13,668.92 lakh in Q2FY26. Profit Before Tax (PBT): Came in at Rs 1,305.12 lakh in Q2FY27, marginally higher by 0.27% QoQ from Rs 1,301.66 lakh in Q1FY27, but lower by 15.16% YoY compared to Rs 1,538.28 lakh in Q2FY26. Profit After Tax (PAT): Reached Rs 983.05 lakh in Q2FY27, showing a growth of 5.47% QoQ from Rs 932.09 lakh in Q1FY27, and declining 19.46% YoY from Rs 1,220.64 lakh in Q2FY26. Total Comprehensive Income: Stood at Rs 983.05 lakh in Q2FY27, increasing 25.90% QoQ compared to Rs 780.84 lakh in Q1FY27, and declining 32.50% YoY compared to Rs 1,456.39 lakh in Q2FY26. Earnings Per Share (EPS): Basic EPS stood at Rs 1.00 per share in Q2FY27, up 5.26% QoQ from Rs 0.95 per share in Q1FY27, and down 20.63% YoY from Rs 1.26 per share in Q2FY26. Diluted EPS stood at Rs 0.98 per share in Q2FY27, up 5.38% QoQ from Rs 0.93 per share in Q1FY27, and down 19.67% YoY from Rs 1.22 per share in Q2FY26. Business Highlights: Segment Performance: The company and the group operate in a single reportable operating segment, "Cardiovascular Devices" (comprising Balloon Catheter, Cardiac Stents, TAVI, and Occluder), as evaluated by the Chief Operating Decision Maker (CODM) under Ind AS 108. Strategic Investment / Acquisition: Approved an investment by Sahajanand Medical Technologies Ireland Limited (wholly owned subsidiary) to acquire additional stake in SNP Medical Corp., a US-based medical device startup registered in Delaware. SMT Ireland holds a 14.15% stake as of September 30, 2026, and with the proposed acquisition costing up to USD 7,80,000 in cash, its shareholding will increase up to 17.19%. IPO Listing: The company's equity shares were listed on BSE and NSE on October 23, 2026, following the completion of an Initial Public Offering (IPO) of 1,38,22,116 equity shares of face value of Re 1 each at an issue price of Rs 344 per equity share via an offer for sale. Result PDF
PDF
06 Nov 2026
Sahajanand Medical Technologies Ltd - 545001 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Publication of Unaudited Financial Results for the quarter and half year ended September 30, 2026 in Newspapers.
PDF

Sahajanand Medical Documents

Sahajanand Medical Earnings Call

Sahajanand Medical earnings calls, including management commentary and AI-generated summaries.

DateTitleLinks
08 Nov 2026Sahajanand Medical Technologies Ltd - 545001 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
05 Nov 2026Sahajanand Medical Technologies Ltd - 545001 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

Sahajanand Medical Credit Ratings

Sahajanand Medical credit ratings from CRISIL and leading rating agencies, assessing financial stability, investment grade, and related PDF documentation.

DateRating AgencyCompany NameDescriptionLinks
02 Nov 2026crisil ratingsSahajanand Medical Technologies LimitedSahajanand Medical Technologies Limited:Ratings upgraded to 'Crisil A- / Stable / Crisil A2+ '; rated amount enhanced for Bank Debt

Sahajanand Medical Investor Presentations

Sahajanand Medical investor presentations, including business updates, financial insights, and strategic initiatives.

DateReport TitleLinks
05 Nov 2026Sahajanand Medical Technologies Ltd - 545001 - Announcement under Regulation 30 (LODR)-Investor Presentation

Sahajanand Medical - Company Profile

Sahajanand Medical Management Structure

Sahajanand Medical management structure with salaries, total experience, and qualifications.

NAMEDESIGNATIONGROSS REMUNERATION ₹(LAC)AS OFHISTORY & DETAILS
Mr. Dr. Krishnankutty SudhirChief Medical Officer399.1Mar 26
Mr. Anil SuriChief Commercial Officer235.5Mar 26
Mr. Abhijeet SinghviSenior Vice President(Research & Development),Chief Technology Officer232.1Mar 26
Mr. Amit Kumar KhandeliaChief Financial Officer219.9Mar 26
Mr. Piyush SavaliaChief Product Officer,Chief Strategy Officer192.7Mar 26
Mr. Russell RozarioSenior Vice President - HR(Human Resources)130.4Mar 26
Mr. Manoj Kumar JainSenior Vice President(Quality,Regulatory Affairs)117.2Mar 26
Mr. Girish KewalramaniChief Information Officer100.7Mar 26
Ms. Bharvi Vardhan ChaurasiaVice President(Corporate,Operations)56.6Mar 26
Deepshikha SinghalCompany Secretary,Compliance Officer41.4Mar 26
BHARGAV DHIRAJLAL KOTADIAManaging Director,Chief Executive Officer-Mar 26

About the company - Business Profile

Sahajanand Medical Technologies was incorporated on September 30, 2001. The company is an R&D-driven; developer of Class III and Class C/D medical devices, focused on Vascular Intervention and Structural Heart solutions. Its portfolio includes coronary stents, balloons, TAVI, occluders, renal stents, and other specialized products

Sahajanand Medical FAQ

Sahajanand Medical today is trading in the red, down by 2.12% at ₹527.6.
Sahajanand Medical is currently trading down 2.12% on an intraday basis. In the past week the stock rose 4.55%. Stock has been up 53.37% in the past quarter and rose 53.37% in the past year. You can view this in the share price history/seasonality section.
Sahajanand Medical is listed on NSE with the ticker SMT and on BSE as 545001. It's currently trading on NSE at a share price of ₹527.6 and on BSE with a share price of ₹520.
The market cap of Sahajanand Medical is ₹5,362.89 Cr. as of Nov 20, 2026.
Sahajanand Medical has never announced any dividend since the time of its listing on the BSE/NSE exchanges.
Sahajanand Medical has never issued stock splits or bonus shares since the time of its listing on the BSE/NSE exchanges.
Sahajanand Medical reported ₹375.65 Cr. in revenue, ₹25.79 Cr. in net profit, and ₹67.79 Cr. in EBITD as of Nov 05, 2026 for Q2 FY26-27.
There are no analyst predictions for stock price target for Sahajanand Medical.
The PE ratio of Sahajanand Medical is not available as of Nov 21, 2026.
The PB ratio of Sahajanand Medical is 7.56 as of Nov 20, 2026.
You can view the latest analyst reports on the Sahajanand Medical reports dashboard. Either click on the Reports tab on this page's sub-header or click here to be directed to the dashboard.
You can set real-time stock alerts on price, volume, SMA, and several other parameters by scrolling to the top of this page and clicking the bell icon on the far right-hand side of the stock overview.